Sales Representative - East Dallas
Trace3Full Time
Entry Level & New Grad
Candidates must possess the ability to provide an integrated MolDx/SaaS solution using Tempus’s sequencing technology, engage in consultative selling, and sell at the executive level. A keen understanding of the payor and reimbursement environment in oncology and diagnostics is required, along with the ability to work independently, manage multiple projects, and prioritize tasks. Strong knowledge of molecular diagnostics for oncology, oncology, hematology, chemotherapeutics, targeted agents, negotiation, customer service, and strategic sales account planning are essential. Proficiency in Microsoft Office Suite, particularly Excel and PowerPoint, and regular utilization of Salesforce.com are necessary. Advanced presentation skills, business acumen, problem-solving abilities, and strong administrative skills are also required.
The Clinical Account Executive will drive strategic business expansion and collaboration opportunities with major U.S. cancer centers, clinics, Key Opinion Leaders, and Academic Medical Centers within the East Tennessee territory. Responsibilities include structuring detailed strategic plans for client acquisition and retention, maximizing client-bill contracting opportunities, and implementing laboratory services agreements. The role involves collaborating with sales positions to achieve company goals, identifying partnering opportunities, promoting compliance with web-based molecular information tools, and analyzing the competitive landscape. The executive will monitor sales performance, develop and implement a comprehensive business plan for the territory, and work effectively with individuals across multiple departments. They will embrace and represent the Tempus company culture and travel frequently throughout the territory.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.